
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy
Weiwei Ren, Dandan Li, Xiaolan Chen, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 5
Open Access | Times Cited: 64
Weiwei Ren, Dandan Li, Xiaolan Chen, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 5
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
Guangtao Pan, Yuhan Liu, Luorui Shang, et al.
Cancer Communications (2021) Vol. 41, Iss. 3, pp. 199-217
Open Access | Times Cited: 246
Guangtao Pan, Yuhan Liu, Luorui Shang, et al.
Cancer Communications (2021) Vol. 41, Iss. 3, pp. 199-217
Open Access | Times Cited: 246
MicroRNA as a Potential Therapeutic Molecule in Cancer
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Cells (2022) Vol. 11, Iss. 6, pp. 1008-1008
Open Access | Times Cited: 76
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Cells (2022) Vol. 11, Iss. 6, pp. 1008-1008
Open Access | Times Cited: 76
Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer
Mingli Han, Jianguo Hu, Pengwei Lu, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 139
Mingli Han, Jianguo Hu, Pengwei Lu, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 139
circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
Yanli Zhang, Chen Li, Xinfeng Liu, et al.
EBioMedicine (2019) Vol. 48, pp. 277-288
Open Access | Times Cited: 108
Yanli Zhang, Chen Li, Xinfeng Liu, et al.
EBioMedicine (2019) Vol. 48, pp. 277-288
Open Access | Times Cited: 108
Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p
Jizhao Wang, Yuchen Sun, Xing Zhang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Jizhao Wang, Yuchen Sun, Xing Zhang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression
Yuxuan Yang, Xiaokun Liu, Di Yang, et al.
Metabolism (2024) Vol. 155, pp. 155905-155905
Closed Access | Times Cited: 11
Yuxuan Yang, Xiaokun Liu, Di Yang, et al.
Metabolism (2024) Vol. 155, pp. 155905-155905
Closed Access | Times Cited: 11
Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers
Mohammad Hossein Pourhanifeh, Massoud Vosough, Maryam Mahjoubin‐Tehran, et al.
Pharmacological Research (2020) Vol. 161, pp. 105133-105133
Closed Access | Times Cited: 62
Mohammad Hossein Pourhanifeh, Massoud Vosough, Maryam Mahjoubin‐Tehran, et al.
Pharmacological Research (2020) Vol. 161, pp. 105133-105133
Closed Access | Times Cited: 62
Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
Zhili Ma, Deliang Guo, Quanxiong Wang, et al.
Theranostics (2019) Vol. 9, Iss. 10, pp. 2967-2983
Open Access | Times Cited: 58
Zhili Ma, Deliang Guo, Quanxiong Wang, et al.
Theranostics (2019) Vol. 9, Iss. 10, pp. 2967-2983
Open Access | Times Cited: 58
Autophagy, an accomplice or antagonist of drug resistance in HCC?
Yafei Wu, Jigang Zhang, Qin Li
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 50
Yafei Wu, Jigang Zhang, Qin Li
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 50
Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer
Yongqi Zhen, Zhaoxin Yuan, Jiahui Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 37
Yongqi Zhen, Zhaoxin Yuan, Jiahui Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 37
Autophagy orchestrates resistance in hepatocellular carcinoma cells
Homeyra Seydi, Kosar Nouri, Niloufar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114487-114487
Open Access | Times Cited: 22
Homeyra Seydi, Kosar Nouri, Niloufar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114487-114487
Open Access | Times Cited: 22
New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.
Shuo Yang, Liang Yang, Xinyu Li, et al.
PubMed (2019) Vol. 9, Iss. 7, pp. 1329-1353
Closed Access | Times Cited: 53
Shuo Yang, Liang Yang, Xinyu Li, et al.
PubMed (2019) Vol. 9, Iss. 7, pp. 1329-1353
Closed Access | Times Cited: 53
Virus, Exosome, and MicroRNA: New Insights into Autophagy
Javid Sadri Nahand, Arash Salmaninejad, Samaneh Mollazadeh, et al.
Advances in experimental medicine and biology (2022), pp. 97-162
Closed Access | Times Cited: 26
Javid Sadri Nahand, Arash Salmaninejad, Samaneh Mollazadeh, et al.
Advances in experimental medicine and biology (2022), pp. 97-162
Closed Access | Times Cited: 26
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives
Safieh Ebrahimi, Seyed Isaac Hashemy
Cellular Oncology (2019) Vol. 42, Iss. 2, pp. 131-141
Closed Access | Times Cited: 37
Safieh Ebrahimi, Seyed Isaac Hashemy
Cellular Oncology (2019) Vol. 42, Iss. 2, pp. 131-141
Closed Access | Times Cited: 37
Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis
Yangwang Pan, Linjing Wu, Shuai He, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 2928-2940
Open Access | Times Cited: 31
Yangwang Pan, Linjing Wu, Shuai He, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 2928-2940
Open Access | Times Cited: 31
Molecular Characteristics, Oncogenic Roles, and Relevant Immune and Pharmacogenomic Features of EVA1B in Colorectal Cancer
Bin Ma, Kangchun Wang, Liang Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Bin Ma, Kangchun Wang, Liang Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
Yuhe Lei, Lei Chen, Junshan Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
Yuhe Lei, Lei Chen, Junshan Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
EVA1A (Eva-1 Homolog A) Promotes Endothelial Apoptosis and Inflammatory Activation Under Disturbed Flow Via Regulation of Autophagy
Lindsay Canham, Sam Sendac, Mannekomba R. Diagbouga, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 4, pp. 547-561
Open Access | Times Cited: 13
Lindsay Canham, Sam Sendac, Mannekomba R. Diagbouga, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 4, pp. 547-561
Open Access | Times Cited: 13
microRNA-125b-1-3p mediates autophagy via the RRAGD/mTOR/ULK1 signaling pathway and mitigates atherosclerosis progression
Xin Chen, Yanhong Cao, Yi‐Ning Guo, et al.
Cellular Signalling (2024) Vol. 118, pp. 111136-111136
Open Access | Times Cited: 4
Xin Chen, Yanhong Cao, Yi‐Ning Guo, et al.
Cellular Signalling (2024) Vol. 118, pp. 111136-111136
Open Access | Times Cited: 4
The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 892-926
Open Access | Times Cited: 26
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 892-926
Open Access | Times Cited: 26
Little things with significant impact: miRNAs in hepatocellular carcinoma
Jiehan Li, Haolin Bao, Ziyue Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Jiehan Li, Haolin Bao, Ziyue Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Mitochondria-associated non-coding RNAs and their impact on drug resistance
Xingna An, Lina Sun, Huan Zheng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Xingna An, Lina Sun, Huan Zheng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
MiR-125b suppresses bladder Cancer cell growth and triggers apoptosis by regulating IL-6/IL-6R/STAT3 axis in vitro and in vivo
Fang Lin, Shaorun Hu, Jinxiang Chen, et al.
Cytokine (2025) Vol. 190, pp. 156926-156926
Closed Access
Fang Lin, Shaorun Hu, Jinxiang Chen, et al.
Cytokine (2025) Vol. 190, pp. 156926-156926
Closed Access